Summary of Purpose
To evaluate the safety and effectiveness of 500mg citicoline compared to placebo in patients who are examined within 24 hours of stroke onset.Read More →
The following dates are available for this trial. Trial information last updated on 28 September 2000.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Interneuron Pharmaceuticals, Lexington, MA
Randomized, double-blind, efficacy trial involving 394 patients at 31 U.S. centers.
Dr. Wayne M. Clark, Oregon Stroke Center UHS 44, Oregon Health Sciences University, 3181 SW Sam Jackson Park Rd, Portland, OR firstname.lastname@example.org